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Abstract
Rationale Major depressive disorder (MDD) has been associ-
ated with disturbances in social functioning and in the brain
serotonin system. Reduced levels of serotonin may negatively
influence social functioning, for example by impairing the
recognition of facial emotion expressions.
Objectives The present study investigated the effect of acute
tryptophan depletion (ATD), which reduces brain serotonin,
on a related component of social functioning, empathic accu-
racy (EA), and oxytocin levels.
Methods Individuals with (FH+) and without (FH−) a family
history of MDD participated in a randomized, double-blind,
crossover study. On two separate test days, participants
ingested tryptophan-deficient and nutritionally balanced ami-
no acid mixtures. Six hours later, they performed an EA task,
which involved watching videos of people recounting
autobiographical emotional events. While watching, partici-
pants continuously rated how these people felt during the
recounting. Mood state was repeatedly assessed using the
Positive Affect and Negative Affect Schedule and a series of
visual analogue scales. Blood samples obtained at baseline
and 5 h after mixture ingestion were assessed for tryptophan
and oxytocin levels.
Results ATD decreased circulating levels of tryptophan and
oxytocin. Nevertheless, there were no significant effects of
ATD on EA or mood in either FH group.
Conclusions While previous studies have shown that acute
reductions in brain serotonin alter the recognition of facial
emotion expressions in never-depressed individuals, the pres-
ent study suggests that empathic abilities may remain
unaffected.
Keywords Serotonin . Empathy . Cognition . Ecological
validity .Major depressive disorder . Oxytocin
Introduction
Individuals with major depressive disorder (MDD) often ex-
perience interpersonal problems (Segrin and Flora 2000).
These problems may be due to excessive reassurance seeking
and demanding support from others, as well as to reduced
levels of prosocial behaviors (Hames, Hagan, and Joiner
2013). Further, depressed individuals often misinterpret facial
emotion expressions (Bourke, Douglas, and Porter 2010;
Demenescu, Kortekaas, den Boer, and Aleman 2010).
Furthermore, their empathic abilities are often impaired
(Schreiter, Pijnenborg, and aan het Rot 2013). As impairments
in empathy may adversely affect social interactions
(Verhofstadt, Buysse, Ickes, Davis, and Devoldre 2008), they
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represent one potential reason for the interpersonal problems
of individuals with MDD (Gadassi, Mor, and Rafaeli 2011).
MDD has also been associated with disturbances in the
brain serotonin system (Mann 2013). Experimental lowering
of serotonin by acute tryptophan depletion (ATD) induces
transient depressive symptoms in recovered MDD patients
(for a review, see Young 2013). Moreover, while never-
depressed individuals without a family history of MDD
(FH−) are generally unaffected by the mood effects of ATD,
individuals with a family history of MDD (FH+) often show a
mild mood worsening (Booij, Van der Does, and Riedel
2003). These and other studies suggest that serotonin plays a
role regulating mood.
Previous ATD studies have also assessed the effects of low
serotonin on aspects of social functioning. In healthy volun-
teers, ATD has been found to decrease cooperative behavior
during the prisoner’s dilemma game (Wood, Rilling, Sanfey,
Bhagwagar, and Rogers 2006) and increase antagonistic re-
sponses in the ultimatum game (Crockett, Clark, Tabibnia,
Lieberman, and Robbins 2008), suggesting that reductions
in serotonin may impair social functioning. Similar studies
have not been performed in recovered MDD patients or in
FH+ versus FH− individuals.
Most other studies on the effects of ATD on aspects of
social functioning have examined facial emotion recognition
(FER). In one study, ATD impaired the recognition of happi-
ness in recovered MDD patients yet enhanced it in controls
(Hayward, Goodwin, Cowen, and Harmer 2005). However, in
healthy never-depressed individuals, ATD has also been found
to impair the recognition of fear (Harmer, Rogers, Tunbridge,
Cowen, and Goodwin 2003; Marsh et al. 2006). Indeed, as the
Bserotonin releaser^ 3,4-methylenedioxymethamphetamine
(MDMA, Becstasy^) has also been found to impair fear rec-
ognition (Bedi, Hyman, and de Wit 2010; Hysek et al. 2014),
the role of serotonin in fear recognition, and more broadly in
FER, remains unclear.
Importantly, the ecological validity of most FER tasks is
considered low, due to the use of static face stimuli
(Hogenelst, Schoevers, and aan het Rot 2015). This precludes
an understanding of the role of serotonin in real-life social
interactions, where facial expressions are dynamic social sig-
nals and therefore important for communicating emotions and
facilitating mutual understanding (Ambadar, Schooler, and
Cohn 2005; Zaki and Ochsner 2012). Also, to know how a
person is feeling, auditory information is at least as important
as visual information (Zaki et al. 2009a). Thus, data obtained
from laboratory tasks involving dynamic facial expressions
and speech may enable better predictions about the role of
serotonin in real-world social functioning than data obtained
from traditional FER tasks.
Nevertheless, abnormal FER is thought to be at the basis of
impaired empathy (Schreiter et al. 2013). If depressed persons
perform poorly at recognizing facial emotions, and interpret
neutral expressions in a negative way (Bourke et al. 2010;
Demenescu et al. 2010), then this may lead them to misread
others’ feelings and misunderstand others’ viewpoints
(Penton-Voak, Allen, Morrison, Gralewski, and Campbell
2007). In other words, depression-associated FER impair-
ments may contribute to empathic stress, a more affective
form of empathy, and to limited empathic accuracy (EA), a
more cognitive form of empathy. EA is considered a form of
cognitive empathy because it constitutes the ability to accu-
rately infer others’ feelings and thoughts from verbal and non-
verbal social information (Ickes 1993). As such, EA is related
to perspective taking and theory of mind (Shamay-Tsoory,
Aharon-Peretz, and Perry 2009). Brain areas whose activity
has been correlated with EA (Zaki et al. 2009b) are known to
be affected by ATD (Nishizawa et al. 1997; Williams, Perrett,
Waiter, and Pechey 2007), suggesting that EA may also be
affected by ATD. EA may be assessed by asking study partic-
ipants (Bperceivers^) to watch video clips of people
(Btargets^) discussing autobiographical emotional events and
rate how the targets were feeling when discussing the events.
Correlations between perceivers’ ratings of targets’ feelings
and targets’ ratings of their own feelings are then used as a
measure of EA. Using naturalistic stimuli increased the eco-
logical validity of this task compared to most FER tasks (Zaki
and Ochsner 2009). The task has previously been found to be
sensitive to between-person differences in empathic abilities
(aan het Rot and Hogenelst 2014; Lee, Zaki, Harvey, Ochsner,
and Green 2011; Ripoll et al. 2013). Moreover, the task is
sensitive to pharmacological interventions within persons
(Bartz et al. 2010). Specifically, intranasal administration of
oxytocin improved EA in healthy individuals with higher
levels of autism spectrum traits (Bartz et al. 2010).
The present study examined the effects of ATD on EA,
oxytocin, and mood in never-depressed individuals with
(FH+) and without (FH−) a first-degree family history of
MDD. ATD in FH+ individuals can be used to model the
effects of low serotonin levels in MDD patients (Booij et al.
2003). FH+ individuals are at increased risk of developing
MDD (Sullivan, Neale, and Kendler 2000), possibly because
theymay exhibit subtle impairments in the processing of emo-
tional stimuli (Mannie, Bristow, Harmer, and Cowen 2007).
These impairments may be exacerbated by low brain seroto-
nin, e.g., following ATD (Feder et al. 2011). Further, after
ATD FH+ individuals have previously been found to respond
differently to negative facial emotion expressions than FH−
individuals (van der Veen, Evers, Deutz, and Schmitt 2007).
Together, these studies indicate that ATDmight also lead FH+
and FH− individuals to be differentially impaired on the EA
task. In line with previous studies on the effects of ATD on the
recognition of negative facial emotion expressions (e.g.,
Harmer et al. 2003; aan het Rot, Coupland, Boivin,
Benkelfat, & Young, 2010), we expected ATD to reduce EA
during videos with negative emotional content. The effects of
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ATD onmood were examined so we could study the effects of
ATD on EA independently of any effects of ATD on mood,
which were also expected to be more pronounced in FH+
individuals than in FH− individuals (Booij et al. 2003).
We also expected ATD to reduce circulating oxytocin
levels. Serotonin can stimulate oxytocin release through
serotonin-1A receptors in the hypothalamus (e.g., Jorgensen
et al. 2003; Thompson et al. 2007). Conversely, reductions in
serotonin may lower oxytocin release. EA may be affected by
low levels of serotonin, low levels of oxytocin, or both.
Methods
Participants
The Medical Ethics Committee of the University Medical
Center Groningen approved the study. Participants provided
written informed consent following an extensive study expla-
nation and were reimbursed 160 euros for their time. The
ClinicalTrials.gov identifier is NCT02051530.
Participants were men and women with (FH+) or without
(FH−) a first-degree family history of MDD. Similar to previ-
ous studies of the effects of ATD on mood and socio-affective
processing in FH+ and FH− individuals (Firk and Markus
2008; Klaassen et al. 1999; Neumeister et al. 2002; van der
Veen et al. 2007), we recruited 20 individuals in each FH
group. FH+ individuals were recruited via patients with a life-
time diagnosis of MDD as verified with their healthcare pro-
vider. Inclusion criteria for FH+ individuals were having at
least one parent, sibling, or child withMDD, age 18–65 years,
no current or past DSM-IVmood disorder includingMDD, no
other current DSM-IVAxis-I disorder, no current major med-
ical illness, and no use of psychotropic medications.
Screening was performed using the Structured Clinical
Interview for DSM-IV Axis-I disorders (First et al. 2002)
and the family history method by Andreasen et al. (1977).
FH− individuals were recruited using advertisements. They
were required to have no first- and second-degree relatives
with a possible (history of) mood disorder (including suicide).
Otherwise, the inclusion criteria were identical. The two
groups were matched for gender, age, and education.
Details of the screening phase can be found in the
Supplementary Material. Briefly, 44 individuals started the
study. Four individuals dropped out (three vomited within
the first hour of mixture ingestion on the first test day and
one felt sick after completing this day). The results are de-
scribed for 10 men and 10 women in the FH+ group (all
children or siblings of MDD patients, including two sister
pairs and one brother pair) and 10 men and 10 women in the
FH− group (all from different families). There were no signif-
icant group differences (Table 1).
Study design and overview
Participants received different amino acid mixtures on two
separate test days in a double-blind cross-over design, with
order of treatment randomized by gender and group in blocks
of four. Participants received a nutritionally balanced mixture
(B) including tryptophan (2.3 g for men, 1.9 g for women) on
1 day and a tryptophan-deficient but otherwise identical mix-
ture (T−) on the other day. The T−mixtures weighed 103 g for
men (Young, Smith, Pihl, and Ervin 1985) and 86 g for wom-
en (Ellenbogen, Young, Dean, Palmour, and Benkelfat 1996).
Water, chocolate syrup or orange juice, and sodium cyclamate
were added just before mixture ingestion.
Biochemical analysis
Blood samples were collected 15 min before and 5 h after
mixture ingestion, using 10-mL Vacutainer tubes containing
K2EDTA solution as anticoagulant, and within 30 min, cen-
trifuged for 10min at 2500 g and 4 °C. Plasma was transferred
to glass tubes and stored at −20 °C until analysis. Total plasma
tryptophan levels were determined using automated online
solid-phase extraction-liquid chromatographic-tandem mass
spectrometry with deuterated internal standards (de Jong,
Smit, Bakker, de Vries, and Kema 2009). Within- and
between-assay coefficients of variation (CVs) were 1.7–
3.6 % and 1.7–7.0 %, respectively. Reference intervals were
45.5–83.1 pM.
Blood oxytocin analysis was performed using radioimmu-
noassay (Dumont et al. 2009). The average recovery was 78±
6 %. Within- and between-assay CVs were 6.4 and 9.7 %,
respectively, at 6.3 pM. The analytical range was 1–90 pM
with a sensitivity of 1.5 pM.
Test measures
Depressive symptoms at baseline were assessed with the
Quick Inventory of Depressive Symptomatology (QIDS-
SR), obtained from www.ids-qids.org (Rush et al. 2003).
Mood state was measured using the Positive Affect and
Negative Affect Schedule (PANAS, Peeters, Ponds, &
Table 1 Participant characteristics
Group
FH− (n=20) FH+ (n=20)
Age in years, mean (SD) 21.9 (2.2) 22.2 (3.3)
Occupation (% student) 90 95
Body mass index (kg/m2), mean (SD) 23.0 (2.1) 22.2 (2.8)
Smoking status (% yes) 30 25
There were no significant group differences by T test (p>0.25 for all)
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Vermeeren, 1996) and a list of visual analogue scales (VAS;
Bond, James, and Lader 1974). The PANAS included 10 pos-
itive affect (PA) items and 10 negative affect (NA) items, all
rated on a 5-point Likert scale. The average of the PA and NA
item scores were used to calculate PA and NA, respectively.
VAS items were rated using 10-cm-long lines ranging from
not at all to extreme. The average of 7 positive mood items
and 5 negative mood item scores was used to calculate VAS(+
) and VAS(−), respectively.
For the psychometric properties of the PANAS and VAS,
see Supplementary Material.
Empathic accuracy task
EAwas assessed using a previously developed computer task,
performance on which was found to be negatively associated
with autism spectrum traits (aan het Rot and Hogenelst 2014).
During the task development phase, described in detail by aan
het Rot and Hogenelst (2014), video clips were collected from
five male and four female targets. After completing the
Berkeley Expressivity Questionnaire (BEQ; Gross and John
1997), targets discussed four negative and four positive auto-
biographical events while being videotaped. After each event,
they rated the overall valence and arousal of their emotions
during the recording and subsequently viewed their clips and
provided continuous ratings of how they felt while speaking.
This was done by moving an on-screen indicator along a 9-
point Likert scale, using a rating dial.
Of the 72 stimulus videos, those rated low on arousal or
with limited temporal variability in the continuous ratings
were discarded. The remaining clips constituted two sets of
20 that were identical in the number of negative and positive
clips and in target representation, and comparable in terms of
clip length, valance, and arousal. The order of these two sets
was randomized over the two test days. On each day, partici-
pants watched one of the sets and continuously rated how they
thought the targets felt while speaking, using the same rating
dial. The order of the clips within each set was randomized per
participant, while never more than two positive or negative
clips in a row and never the same target more than twice in a
row. Participants’ and targets’ raw data were averaged across
5-s periods. Autocorrelations were removed using the Yule-
Walker method. EA scores were calculated per participant per
video clip using Fisher z-transformed correlations between
participant ratings and target ratings.
Procedures
Test days were separated by at least 3 days (mean 7.8 days).
Women were tested in the follicular phase. Testing took place
in a private room with standard room lighting turned on and
blinds and curtains closed. Before each test day, participants
maintained a 24-h low-protein diet. They arrived at the lab at
08:30 am, following an overnight fast. Urine samples were
collected to test for recent drug use (Triage™ Panel for
Drugs of Abuse, Biosite Incorporated®, San Diego, CA)
and, in women, for pregnancy (QuickVue hCG urine test,
Quidel, San Diego, CA).
Participants then completed the QIDS-SR, PANAS, and
VAS (t0). Approximately 15 min later, a first blood sample
was drawn. Subsequently, participants were given up to
30 min to ingest the amino acid mixture. Afterwards, partici-
pants were allowed to study, read, and watch a limited set of
movies, but not sleep. Besides the mixture and unlimited tap
water, no food or beverages were allowed. Mood state was
assessed 5, 6, and 7 h after mixture ingestion (t5–t7). Between
t5 and t6 (i.e., around 2.30 pm), a second blood draw took
place, followed by an assessment of behavioral mimicry and
speech (data not presented here). Between t6 and t7, the EA
task was administered. After t7, participants were given a
sandwich and two capsules with 500 mg tryptophan
(ElvitaalTM, Lunteren, The Netherlands). After going home,
they were followed up by telephone in the evening and the
next day. See Fig. 1 for a schematic overview.
Data analysis
Differences in participant characteristics between the FH
groups were examined using T tests. Morning baseline data
were investigated using general linear modeling (GLM) with
group (FH+, FH−) as between-subjects factor and mixture (T
−, B) as within-subjects factor. All models included mixture,
group, and their interactions. T tests andGLMwere performed
in SPSS 17.0.
The effects of ATD were analyzed using hierarchical linear
modeling (HLM) with maximum likelihood estimation to
compute the denominator degrees of freedom for the fixed
effects tests. HLM was performed with R v3.0.2 (www.r-
project.org).
For the primary outcome variable (EA), the model consid-
ered mixture, group, and the mixture × group interaction.
Secondary variables were plasma tryptophan and oxytocin
levels, PA, NA, VAS(+), and VAS(−). For plasma tryptophan
and oxytocin levels, the models considered mixture, group,
sample (morning, afternoon), and their interactions. For PA,
NA, VAS(+), and VAS(−), the models considered mixture,
group, time (0, t5, t6, t7), and their interactions.
We had no a priori hypotheses about gender or mixture ×
gender effects on EA. Yet, as women may be more susceptible
to the mood effects of ATD, we added gender as a covariate to
the analyses described in the previous paragraphs. We added
order (T− first, B first) as a second covariate.
Significance was set at 0.05. Significant interaction terms
were analyzed post hoc using simple contrasts, including
Tukey-Kramer corrections for multiple comparisons. Results
of HLM are reported using estimated least-squares means and
114 Psychopharmacology (2016) 233:111–120
standard errors of the mean (SEM). Cohen’s d was used to
indicate effect sizes when comparing two means.
Results
Baseline mood
Morning QIDS scores did not vary significantly by mixture
(F(1,37)=0.11, p=0.74, d=0.11) and group (F1,37=3.07, p=
0.09, d=0.58). The mixture × group interaction was signifi-
cant (F1,37=4.55, p=0.04), but post hoc comparisons revealed
no significant effects (all ps>0.06). Notably, no participant
scored >7 on the QIDS. For baseline PA, NA, VAS(+), and
VAS(−), there were no significant effects of mixture, group,
and the mixture × group interaction (see Table 2).
Empathic accuracy
One participant thought he recognized one target, and one
thought he recognized two targets. We discarded the data
pertaining to these participant/target combinations. The two
sets of film clips generated similar mean levels of EA (set 1
v. set 2: 0.61 [SEM 0.02] v. 0.62 [SEM 0.02], t(1547)=−0.31,
p>0.75).
The main model revealed no significant effects for group
(F(1,40)=0.08, p=0.78, d=0.09), mixture (F(1,1548)=0.60,
p=0.44, d=0.04), and mixture × group (F(1,1548)=0.01, p=
0.90). This suggested that ATD did not significantly alter EA
in either group.
As EAwas higher for positive clips (mean r=0.72) than for
negative clips (mean r=0.51) (F(1,1548)=149.9, p<0.001,
d=0.62), we examined whether clip valence moderated the
effect of ATD on EA. The mixture × valence interaction
(F(1,1548)=0.08, p=0.78) and the mixture × group × valence
interaction (F(1,1548)=2.88, p=0.09) were not significant.
As EA was higher for female targets (mean r=0.64) than
for male targets (mean r=0.51) (F(1,1551)=29.9, p<0.001,
d=0.28), we examined whether target gender moderated the
effect of ATD on EA. The mixture × target gender interaction
(F(1,1548)=0.02, p=0.90) and the mixture × group × target
gender interaction (F(1,1548)=1.26, p=0.26) were not signif-
icant. We also considered target expressivity as a moderator of
the effect of ATD on EA. Results (not shown) were similar to
the results where target gender was included as moderator.
All analyses were repeated for the two FH groups separate-
ly, for the two participants genders separately, for the two
target genders separately, and for the positive and negative
clips separately. The effects of mixture or group × mixture
were never significant (all ps>0.13). This suggests the study
was not underpowered. In short, we did not find any effects of
ATD on EA.
Table 2 F values for the effects of mixture, group, and mixture × group
on baseline mood
PA NA VAS(+) VAS(−)
Mixture 0.15 0.31 0.03 <0.01
Group 0.04 3.33 0.84 0.17
Mixture × group 1.36 0.07 0.50 0.57
PA positive affect, NA negative affect, VAS(+) visual analogue scale pos-
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Fig. 1 Timeline of events on the
two test days for a typical
participant
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Tryptophan and oxytocin
Two morning blood samples were not obtained. For trypto-
phan, the mixture × sample interaction was significant (F(1,
118)=443.41, p<0.001). Total tryptophan levels decreased
from 61.6 μM (SEM 2.1) to 7.1 μM (SEM 2.1) following T
−, t(116)=20.16, p<0.0014, d=3.74, and increased from
61.0 μM (SEM 2.1) to 84.1 μM (SEM 2.1) following B,
t(116)=−8.67, p<0.001, d=1.61. The minimum decrease fol-
lowing T− was 77 % (mean 89 %). As the mixture × group ×
sample interaction was not significant (F(1,118)=1.78, p=
0.18), the effect of ATD on total tryptophan levels was similar
in the two FH groups.
Nearly two thirds of the oxytocin values were below the
detection threshold of 1.5 pM. The number of missing values
did not differ significantly between the morning and afternoon
(Χ2 (1, N=101)=4.62, p=0.20). To examine the effects of
ATD on oxytocin, the 13 participants with at least one detect-
able value per test day (5 FH+ men; 3 FH+ women; 2 FH−
men; 3 FH− women) were included in the analyses with their
undetectable values conservatively recoded to 1.5 pM. The
mixture × sample interaction was significant (F(1,39)=6.00,
p=0.02). Oxytocin levels significantly decreased from morn-
ing to afternoon following T− (t(33)=5.36, p<0.001, d=1.87)
but not following B (t(33)=2.17, p=0.15, d=0.76). The mix-
ture × group × sample interaction was not significant (F(1,
39)=1.66, p=0.21).
In sum, ATD was effective in reducing total tryptophan
levels and also appeared to reduce oxytocin levels. The two
FH groups were not differentially affected.
Oxytocin and EA
As ATD reduced oxytocin levels in the participants with us-
able data, we explored whether their afternoon oxytocin levels
were predictive of EA. This was not found (F(1,38)=0.70, p=
0.41, d=0.27). The correlation r between afternoon oxytocin
levels and mean EA across film clips was 0.01, p=0.99.
Mood state
Table 3 summarizes the effects of mixture, group, time, and
their interactions on mood.
PAThere was a significant main effect for mixture. The mix-
ture × group interaction was also significant. In FH+ partici-
pants, PA was lower on the T− day (M=2.45, SEM=0.14)
than on the B day (M=2.66, SEM=0.14 (t(266)=3.85,
p<0.001, d=0.47). In FH− participants, PA did not differ be-
tween the T− day (M=2.46, SEM=0.14) and the B day (M=
2.47, SEM=0.14) (t(266)=0.19, p>0.99, d=0.02). There was
also a significant main effect for time. PAwas higher at t0 (M=
2.66, SEM=0.10) than at t6 (M=2.51, SEM=0.10) (t(266)=
2.81, p=0.03, d=0.34) and t7 (M=2.34, SEM=0.10) (t(266)=
5.79, p<0.001, d=0.71). More importantly, however, there
were no significant effects of mixture × time and mixture ×
group × time, indicating that levels of PA did not change
differently on the T− day compared to the B day.
NAThere was only a significant main effect for time. NAwas
significantly higher at t0 (M=1.11, SEM=0.02) than at t6
(M=1.05, SEM=0.02) (t(266)=3.22, p=0.008, d=0.39).
VAS(+) The mixture × group interaction was significant. In
FH+ participants, VAS (+) was lower on the T− day (M=
42.99, SEM=2.92) than on the B day (M=46.41, SEM=
2.92) (t(266)=2.75, p=0.03, d=0.34). There was also a sig-
nificant main effect for time. VAS(+) was significantly higher
at t0 (M=49.33, SEM=2.16) than at t5 (M=45.36, SEM=
2.16) (t(266)=3.18, p=0.008, d=0.39), t6 (M=44.39,
SEM=2.16) (t(266)=3.97, p<0.001, d=0.49), and t7 (M=
44.31, SEM=2.16) (t(266)=4.03, p<0.001, d=0.49).
However, there were no significant effects of mixture × time
and mixture × group × time, indicating that levels of positive
mood did not change differently on the T− day compared to
the B day.
VAS(−) There was a significant main effect for time. VAS(−)
was significantly lower at t0 (M=5.76, SEM=0.90) than at t7
(M=7.02, SEM=0.90) (t(266)=−2.66, p=0.04, d=0.33). The
group × time interaction was also significant. However, post
hoc contrasts between morning and afternoon VAS(−) levels
were not significant for either FH group (all ps>0.06).
In sum, mood state varied somewhat over the course of the
test days. However, the time pattern did not differ by mixture.
In other words, ATD did not influence mood.
Table 3 F values for the effects of mixture, group, time, and their
interactions on mood
PA NA VAS(+) VAS(−)
Gender 1.84 <0.01 0.70 0.38
Order 3.31 0.22 1.74 0.07
Mixture 8.56** 0.18 1.65 0.25
Group 0.25 1.82 0.01 0.76
Time 11.84*** 3.74* 7.64*** 5.31**
Mixture × group 7.04** 0.16 4.23* 0.02
Mixture × time 0.25 0.85 0.57 0.73
Group × time 0.57 0.83 1.98 2.70*
Mixture × group × time 0.17 0.51 0.36 0.15
PA positive affect, NA negative affect, VAS(+) visual analogue scale pos-
itive mood, VAS(−) visual analogue scale negative mood
*p<0.05; **p<0.01; ***p<0.001
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Discussion
We found no significant effect of ATD on empathic accuracy
(EA) in individuals with (FH+) and without (FH−) a family
history of MDD, though ATD significantly reduced blood
oxytocin levels.
Previous research has indicated that, in healthy never-
depressed individuals, ATD can have a negative impact on
aspects of social functioning other than EA, such as facial
emotion recognition (FER) (Harmer et al. 2003) and cooper-
ation during the prisoner’s dilemma game (Wood et al. 2006).
These findings suggest that ATD can impair performance on
tasks that require participants to respond to limited social in-
formation. In contrast, we found that ATD did not impair
performance on a task that involves responding to social in-
formation presented in a more dynamic, multimodal, and re-
alistic way. While ATD may have impaired the processing of
negative facial expressions (cf. Harmer et al. 2003; aan het Rot
et al. 2010; van der Veen et al. 2007), participants in our study
may have been able to maintain good EA because other (e.g.,
visual plus auditory) information was available. Moreover,
there is evidence from experimental studies that ecstasy, an
acute serotonin releaser, may have few effects on cognitive
empathy even though more affective forms of empathy can
improve (Hysek and Liechti 2012; Hysek et al. 2014; Schmid
et al. 2014). In other words, in healthy, never-depressed indi-
viduals acute reductions in brain serotonin may negatively
impact affective empathy but not cognitive empathy (Hysek
et al. 2014; Schmid et al. 2014).
Both FH groups maintained good EA during ATD. This
was unexpected as previous studies indicated that FH+ indi-
viduals may be more susceptible to the effects of ATD on the
processing of socio-affective information (Feder et al. 2011;
Firk and Markus 2008; van der Veen et al. 2007). This sus-
ceptibility has been suggested to indicate a risk factor for the
development of depression. Mean levels of EAwere compa-
rable in the two FH groups and similar to levels seen in pre-
vious studies (aan het Rot and Hogenelst 2014; Zaki, Bolger,
and Ochsner 2008). Therefore, alterations in EA induced by
low serotonin might not play a role in the elevated MDD risk
of FH+ individuals compared to FH− individuals.
The absence of an effect of ATD on EA cannot be attribut-
ed to an insufficient depletion of tryptophan. Five hours after
ingestion of the T− mixture, total plasma levels of tryptophan
were on average reduced by 89 %. This is similar to previous
studies (e.g., Feder et al. 2011; Firk and Markus 2008; van der
Veen et al. 2007). A lack of statistical power was also deemed
an unlikely explanation for the lack of a significant effect of
ATD on EA.We repeated the planned analyses of the effect of
ATD on EA in the two FH groups separately (n=20 per
group), and there was no significant effect of ATD on EA in
either group. Similarly, we repeated the analyses in the two
genders separately (n=20 per gender) and there was no
significant effect of ATD on EA in either gender. The effect
size d was never greater than 0.11. Moreover, our sample size
was comparable with that of previous FH+ studies on the
effects of ATD on socio-affective processing (Feder et al.
2011; Firk and Markus 2008; van der Veen et al. 2007).
In a subgroup of 13 participants with usable data, ATD
significantly reduced circulating oxytocin levels. As oxytocin
levels were often below the detection threshold, the finding
that ATD reduced oxytocin requires replication. Nevertheless,
the finding appears to be in line with previous studies in which
stimulation of the brain serotonin system increased oxytocin
release (e.g., Jorgensen et al. 2003; Lee, Garcia, van de Kar,
Hauger, and Coccaro 2003; Ramos et al. 2013; Thompson
et al. 2007). Our results extend these findings by suggesting
that an acute reduction in brain serotonin may decrease oxy-
tocin release.
The finding that ATD reduced circulating oxytocin levels
but not EA appears to be at odds with a previous study in
which intranasal oxytocin administration improved EA in in-
dividuals with higher levels of autism spectrum traits (Bartz
et al. 2010). This study suggests there is a positive association
between brain levels of oxytocin and EA. However, this effect
was not seen in individuals with lower levels of autism spec-
trum traits, and we do not know the levels of these traits in our
participants. Moreover, while brain levels of oxytocin are like-
ly altered when oxytocin is administered intranasally and
blood levels of oxytocin may be altered by ATD, it is unclear
whether brain levels of oxytocin were altered by ATD. Basal
concentrations of oxytocin in blood plasma and cerebrospinal
fluid may not be correlated (Striepens et al. 2013).
We had expected FH+ individuals in particular to be sensi-
tive to ATD-induced mood lowering (Booij et al. 2003; van
der Veen et al. 2007), but ATD did not significantly lower
mood in either FH group. Nevertheless, other ATD studies
have also found no difference in mood change between FH+
and FH− individuals (e.g., Ellenbogen, Young, Dean,
Palmour, and Benkelfat 1999; Feder et al. 2011). It has previ-
ously been suggested that FH+ participants with no personal
psychiatric history and who do not drop out of the study con-
stitute a group with low susceptibility to ATD-induced mood
change (Ellenbogen et al. 1999). In the present study, there
were few exclusions and dropouts, but it remains possible that
FH+ individuals with a psychiatric history were not screened
because they were not recruited.
Limitations
The family history method we used provides insight in inter-
individual variability in familial MDD load. However, it does
not yield diagnoses in family members (Andreasen et al.
1977). FH+ individuals with multiple family members diag-
nosed with MDD may respond differently to ATD than FH+
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individuals with a single affected family member. We could
not formally test this.
Differential effects of ATD in our study versus previous
studies assessing the effects of ATD on responses to socio-
affective information and mood in FH+ individuals (Feder
et al. 2011; Firk and Markus 2008; van der Veen et al. 2007)
may be explained by between-study differences in MDD pa-
tient characteristics such as symptom levels, number of expe-
rienced depressive episodes, and medication status. We did
not collect information on these characteristics nor did several
previous studies (e.g., van der Veen et al. 2007; Firk and
Markus 2008). This precludes comparing our study with these
previous studies. An exception is a study by Feder et al.
(2011), who only included patients with recurrent or chronic
MDD who had been prescribed antidepressant medication.
Future studies may include more elaborate patient
information.
By asking participants to rate how targets in the video clips
felt, the EA task is thought to assess cognitive empathy. While
the task could have been adapted to assess the more affective
aspects of empathy, by asking participants to rate how they felt
while listening to the targets, this was not done. Moreover,
though the EA task uses stimuli with high ecological validity
and performance is impaired in clinical groups with social
deficits (Lee et al. 2011; Ripoll et al. 2013), the predictive
value of the task for everyday social functioning has not been
determined. This limits the extent to which the results of our
study are relevant for real life. However, FER task perfor-
mance may also be unrelated to everyday social functioning
(Janssens et al. 2012).
ATD did not significantly lower mood or alter EA. Yet, EA
may have been affected by ATD if there had been effects on
mood. It therefore remains an open question whether a sample
of FH+ individuals who do experience mood changes after
ATD would also show effects on EA.
Suggestions for future studies
Remitted MDD patients are more sensitive to the mood-
lowering effect of ATD than never-depressed individuals
(Young 2013). Moreover, in remitted MDD patients, ATD
has previously been shown to impair the recognition of happy
facial expressions (Hayward et al. 2005). Given their suscep-
tibility to mood lowering and impaired FER after ATD, com-
pared to FH+ individuals, remitted MDD patients may be
more susceptible to ATD-induced impairments in EA. This
could be assessed in a future study and may inform about
the neurobiology underlying impaired empathy in MDD
(Schreiter et al. 2013).
Depressed individuals’ interpersonal difficulties are espe-
cially likely to emerge in the context of intimate relationships
(Segrin and Flora 2000). In a future study involving FH+
individuals, ATD could be combined with a laboratory
paradigm that involves assessment of EA during an interac-
tion in which couples are asked to collaborate. This has pre-
viously been done in a study that found depressed individuals
to have worse EA than nondepressed individuals (Gadassi
et al. 2011).
Conclusion
Previous research indicates that acute reductions in brain se-
rotonin can impair behavioral responses to static facial expres-
sions in healthy individuals, including those at familial risk for
MDD (aan het Rot et al. 2010; Harmer et al. 2003; van der
Veen et al. 2007). Our results suggest that when social stimuli
are more realistic, even though brain oxytocin levels may be
reduced, behavioral responses may remain intact.
The present study does not provide evidence for a role of
serotonin in regulating empathic abilities in never-depressed
individuals. Additional experiments are needed to determine
whether serotonin regulates empathic abilities in individuals
with MDD and whether this is mediated by oxytocin.
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